Gramicidin Inhibits Lung Cancer Metastasis by Suppressing the ABL‐MMP9 Signaling Axis
- 1Department of Pulmonary and Critical Care Medicine, Hunan Provincial People's Hospital The First Affiliated Hospital of Hunan Normal University Changsha China
Abstract
Lung cancer, the deadliest malignant tumor worldwide, consists predominantly of non‐small cell lung cancer (NSCLC) and accounts for most cancer‐related deaths; its aggressive metastatic nature severely compromises treatment outcomes and overall survival. Abelson tyrosine kinase (ABL), a key regulator of metastasis across multiple tumor types, has emerged as a promising therapeutic target. Gramicidin's effects on NSCLC cell proliferation, migration, and invasion were assessed using CCK‐8, colony formation, Transwell, and wound healing assays. ABL protein levels were analyzed using Western blot (WB). The effects of ABL expression on MMP9 levels and cellular migration and invasion were examined in ABL‐knockdown cells using gelatin zymography, WB, Transwell, and wound healing assays. ABL‐overexpressing cells were treated with gramicidin to examine gramicidin's suppression of the ABL‐MMP9 axis using WB, Transwell, and wound healing assays. In a BALB/c nude mouse model of lung metastasis established via tail vein injection of tumor cells, we evaluated the inhibitory effects of gramicidin on metastatic nodule formation in vivo and its influence on ABL and MMP9 expressions. Gramicidin significantly suppressed lung cancer cell proliferation, migration, and invasion. ABL was upregulated in human lung cancer cells and could be effectively suppressed by gramicidin treatment. Gramicidin downregulated MMP9 expression by suppressing ABL protein expression, thereby attenuating lung cancer metastasis. In vivo, gramicidin treatment reduced the number of lung metastatic nodules and simultaneously downregulated ABL and MMP9 proteins in lung tissue, effects that were partially reversed by ABL overexpression. This study revealed the molecular mechanism by which gramicidin inhibits lung cancer metastasis through suppression of the ABL‐MMP9 axis, providing a theoretical foundation for developing gramicidin‐based anti‐metastatic strategies.
Related
- A marine-derived sesterterpenoid inhibits migration and invasion of triple-negative breast cancer cells by suppressing the FAK signaling pathway
- SSPH I, a Novel Anti-Cancer Saponin, Inhibits Autophagy and Induces Apoptosis via ROS Accumulation and ERK1/2 Signaling Pathway in Hepatocellular Carcinoma Cells [Retraction].
- MZF1 Inhibits TGFβ-1/SMAD Signaling by Transcriptionally Activating SnoN to Augment Tumorigenic Potential in Colon Cancer.
- Panaxadiol derivatives inhibit lung metastasis of breast cancer via DLL4-Notch signaling pathway and palmitoyl carnitine aggregation
- Licochalcone A Inhibits Melanoma Cell Survival by Suppressing HSP75 (TRAP1) and Disrupting Cellular Redox and Energy Homeostasis
BibTeX
@article{li2026gramicidin,
title = {{Gramicidin Inhibits Lung Cancer Metastasis by Suppressing the ABL‐MMP9 Signaling Axis}},
author = {Xiuying Li and Ling Chen},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2026},
month = nov,
doi = {10.1002/jbt.71156},
url = {https://doi.org/10.1002/jbt.71156},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Gramicidin Inhibits Lung Cancer Metastasis by Suppressing the ABL‐MMP9 Signaling Axis
AU - Xiuying Li
AU - Ling Chen
PY - 2026
DA - 2026/11/04
JO - Journal of Biochemical and Molecular Toxicology
DO - 10.1002/jbt.71156
UR - https://doi.org/10.1002/jbt.71156
AB - Lung cancer, the deadliest malignant tumor worldwide, consists predominantly of non‐small cell lung cancer (NSCLC) and accounts for most cancer‐related deaths; its aggressive metastatic nature severely compromises treatment outcomes and overall survival. Abelson tyrosine kinase (ABL), a key regulator of metastasis across multiple tumor types, has emerged as a promising therapeutic target. Gramicidin's effects on NSCLC cell proliferation, migration, and invasion were assessed using CCK‐8, colony formation, Transwell, and wound healing assays. ABL protein levels were analyzed using Western blot (WB). The effects of ABL expression on MMP9 levels and cellular migration and invasion were examined in ABL‐knockdown cells using gelatin zymography, WB, Transwell, and wound healing assays. ABL‐overexpressing cells were treated with gramicidin to examine gramicidin's suppression of the ABL‐MMP9 axis using WB, Transwell, and wound healing assays. In a BALB/c nude mouse model of lung metastasis established via tail vein injection of tumor cells, we evaluated the inhibitory effects of gramicidin on metastatic nodule formation in vivo and its influence on ABL and MMP9 expressions. Gramicidin significantly suppressed lung cancer cell proliferation, migration, and invasion. ABL was upregulated in human lung cancer cells and could be effectively suppressed by gramicidin treatment. Gramicidin downregulated MMP9 expression by suppressing ABL protein expression, thereby attenuating lung cancer metastasis. In vivo, gramicidin treatment reduced the number of lung metastatic nodules and simultaneously downregulated ABL and MMP9 proteins in lung tissue, effects that were partially reversed by ABL overexpression. This study revealed the molecular mechanism by which gramicidin inhibits lung cancer metastasis through suppression of the ABL‐MMP9 axis, providing a theoretical foundation for developing gramicidin‐based anti‐metastatic strategies.
SN - 1095-6670
SN - 1099-0461
ER -